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operation had failure of the re-repair result-
ing from recurrent mitral regurgitation in 5
and hemolysis in 1.
We are grateful to the Editor for the
opportunity to further clarify these points.
Rakesh M. Suri, MD, DPhil
Hartzell V. Schaff, MD
Cardiovascular Surgery
Mayo Clinic College of Medicine
Rochester, Minn
doi:10.1016/j.jtcvs.2007.03.008
Limitations with aprotinin in thoracic
aortic surgery: Understanding the
clinical outcome beyond bleeding
To the Editor:
I read with great interest the recent article
by Dr Sedrakyan and colleagues1 detailing
their experience with aprotinin in thoracic
aortic surgery, using a retrospective case-
control matching analysis (n  168 [1995-
2003]: deep hypothermic circulatory arrest
(DHCA) 64.3%–67.9%). The authors con-
clude in their article that there is American
Heart Association level II evidence for
aprotinin in thoracic aortic surgery.
I have the following questions for the
authors of this excellent study:
1. What was the reexploration rate for
bleeding in this case-control series?
Did antifibrinolytic exposure make
any difference? This outcome vari-
able is an important determinant of
mortality after thoracic aortic sur-
gery.2 It would be useful to know
whether aprotinin was associated
with a lower take-back rate.
2. Were anesthetic technique and an-
esthetic drug doses equivalent in
both groups? This is an important
determinant of postoperative venti-
lation time. Was this potential con-
founder considered before conclud-
ing that aprotinin is associated with
a decrease in total ventilation time?
3. Were the clinical outcomes, includ-
ing renal failure and dysfunction,
equivalent in the subgroup with
DHCA? Our group has recently re-
ported that aprotinin may be associ-
ated with renal dysfunction after
DHCA.3 Does a mixed thoracic aor-
tic cohort explain the differences in
these studies?
4. Were there criteria for antifibrino-
lytic choice in this cohort (eg, pre-
vious aprotinin exposure; level of
renal impairment)? When was the
aprotinin administered (eg, before
skin incision or after dissection
and cannulation for cardiopulmo-
nary bypass)? It would be useful to
understand the dosing style of apro-
tinin in this study.
5. Were there any hypersensitivity re-
actions to aprotinin?4 Were there
any cases of unexpected vascular
thrombosis?5
I look forward to input from the authors.
Again, I congratulate them for a most valu-
able article on this challenging topic.
John G. T. Augoustides, MD, FASE
Department of Anesthesiology and Critical Care
Hospital of the University of Pennsylvania
Philadelphia, PA
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Reply to the Editor:
We appreciate Dr Augoustides’ kind com-
ments regarding our article.1 We are very
much aware of the important contributions
he and his colleagues have made on the
topic at hand.
We provide the following specific re-
sponses to the insightful comments and
questions raised in Dr. Augoustides’ letter.
1. Three patients required reexplora-
tion for bleeding—1 in the aprotinin
group and 2 in the control group.
2. Anesthesia was by a balanced nar-
cotic/inhalation technique in both
groups.
3. Renal failure occurred in 3 patients
in the control group and 2 in the
aprotinin group.
4. Aprotinin was administered after
the skin incision. It is our policy to
avoid aprotinin in the rare circum-
stance of recent prior aprotinin ex-
posure.
5. There were no clinically appreciated
hypersensitivity reactions to aproti-
nin. There were no cases of unex-
pected vascular thrombosis.
In sum, the points raised by Dr Augous-
tides are all very cogent. On each point,
there was, in our study, no evidence of
adverse aprotinin-related outcome.
Artyrom Sedrakayan, MD
Maryann Tranquilli, RN
John A. Elefteriades, MD
Department of Cardiothoracic Surgery
Yale University School of Medicine,
New Haven, CT
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Unilateral as well as bilateral
infiltrates should remain part of the
definition of pulmonary graft
dysfunction
To the Editor:
We read with interest the article by Oto and
associates1 in the December 2006 issue of
the Journal. The authors underestimate the
importance of unilateral infiltrates. We dis-
agree with the statement, “only bilateral
infiltrates should be used as part of the
definition of primary graft dysfunction” de-
spite their convincing statistical methods.
We explain why.
The guidelines of pulmonary graft dys-
function (PGD)2 and validation3 thereof is
for the clinician to make sense of the data
and standardize reporting. The emphasis by
the consensus committee on PGD was on
providing a definition that could also help
in management and prognosis.2 PGD is a
biological process of reperfusion–ischemic
injury redefined with respect to alveolar–
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capillary injury. This process is biological,
with reversible and irreversible path-
ways4,5 and along a spectrum that cannot
be dichotomous, hence the association of
time, arterial oxygen tension/inspired oxy-
gen fraction (PaO2/FIO2) ratios and radio-
graphic findings that are in the context of
the International Society of Heart and Lung
Transplantation definition. The authors do
not reveal their perioperative bronchoscopy
protocol, which itself can influence radio-
graphic findings with respect to presence or
absence of infiltrates. It is not uncommon
that infiltrates could be due to segmental
and/or subsegmental mucus plugging,
which when it extends to main bronchi can
cause significant ventilation–perfusion
mismatch and reduction of PaO2/FIO2 ra-
tios. The population sample, as quite cor-
rectly stated by the authors, remains small
and heterogeneous; primary pulmonary hy-
pertension is a bilateral problem and re-
quires bilateral lung transplantation. The
authors should analyze their findings with
respect to a clean cohort of infectious lung
disease, for example, to avoid the con-
founding effect of pulmonary hyperten-
sion. The reader will soon realize that the
majority of patients with pulmonary hyper-
tension were among the cohort with bilat-
eral infiltrates.
Moreover, patients with fixed pulmo-
nary hypertension are more likely to expe-
rience reperfusion–ischemic injury with
higher PGD grades.5 Recently, aprotinin
has been shown to reduce reperfusion in-
jury and allograft dysfunction. It is unclear
from the manuscript which antifibrinolytic
was administered during transplantation—
the type of antifibrinolytic being a potential
confounder. The authors state that unilat-
eral infiltrates were associated with PGD
grade 3, but that diminished at T48 hours.
However, when compared with the absence
of infiltrates at T0, it had decreased. It may
be more appropriate to look at the absolute
difference from T0 to T48 rather than the
relative difference, which in a larger homo-
geneous population sample would mini-
mize confounding. Short of radiographic
findings, a clinician can be at loss if PaO2/
FIO2 ratios are the only information pro-
vided to make a diagnosis of PGD and/or to
intervene with medical therapy or bron-
choscopy. Given the therapeutic and diag-
nostic power of bronchoscopy, any infil-
trate on the chest radiograph is of
paramount importance in decision making
and detection of this biological PGD pro-
cess. Furthermore, despite the inherently
subjective interpretation of a chest radio-
graph, a transplant physician can recognize
patterns of unilateral infiltrates that are typ-
ical of the most severe and rapidly pro-
gressing to grade 3 PGD, which could go
unnoticed if only bilateral infiltrates are
considered.
Jeffrey Shuhaiber, MD
Department of Thoracic
and Cardiovascular Surgery
Loyola University Medical Center
Chicago, Ill
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Reply to the Editor:
The aims of our study were to describe the
difference of unilateral and bilateral radio-
graphic infiltrates on early posttransplant
outcomes, including primary graft dysfunc-
tion (PGD) grade.1,2 As Shuhaiber states, a
perioperative bronchoscopy protocol could
influence radiographic findings. In our pro-
tocol, inspection and toileting bronchos-
copy was routinely performed before donor
lung procurement, immediately after im-
plantation, and within 6 hours after admis-
sion to the intensive care unit. Therefore,
significant airway secretions or mucus
plugging were unlikely to be present in the
early postoperative period. Moreover, for
the purpose of PGD grading, only radio-
graphic infiltrates, consistent with pulmo-
nary edema rather than atelectasis, were
assessed (as per the International Society
for Heart and Lung Transplantation PGD
grading guideline.2).
Notwithstanding, mucus plugging, clot,
or extubation itself3 could cause a tempo-
rary reduction of arterial oxygen tension/
fraction of inspired oxygen (PaO2/FIO2) ra-
tio. Therefore, the worst PaO2/FIO2 ratio
might not represent true graft function4 and
should not be used for PGD grading.
Pulmonary hypertension (PH) is a sig-
nificant risk factor for posttransplant radio-
graphic infiltrates. In our study, the number
of patients with PH was small; thus, the
majority of bilateral infiltrates were seen in
the non-PH patient group. Moreover, the
official PGD grading system applies to
both PH and non-PH recipients.
Antifibrinolytic agents were used for
patients having a higher risk of bleeding
(eg, cardiopulmonary bypass, previous tho-
racic operation), patients already at in-
creased risk of postoperative pulmonary in-
filtrates. Therefore, in this circumstance,
the radiographic infiltrates are potentially
multifactorial.
Although further study including multi-
variate analysis is needed, our study clearly
showed that the early posttransplant out-
come of the unilateral infiltrates was simi-
lar to that in the group having a clear chest
x-ray film and significantly better than that
in those with bilateral infiltrates. Therefore,
we believe that in bilateral lung transplan-
tation, only bilateral infiltrates should be
used as part of the definition of PGD.
Takahiro Oto, MDa
Gregory I. Snell, MDb
Department of Thoracic Surgery
Okayama University Hospitala
Okayama, Japan
Allergy, Immunology and Respiratory Medicine
The Alfred Hospitalb
Melbourne, Australia
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